Skip to main content

Table 2 meta-analysis results of 25 lncRNAs

From: The value of lncRNAs as prognostic biomarkers on clinical outcomes in osteosarcoma: a meta-analysis

LncRNA name

No. of patients

No. of studies

HR(95%CI)-model

P value

heterogeneity

I2

P

BCAR4

228

2

2.36 (1.13, 4.93)-fixed

0.022

0.0%

0.453

CCAT2

90

2

2.18 (0.81, 5.86)-random

0.123

71.2%

0.062

DANCR

129

2

1.65 (0.76, 3.60)-random

0.209

57.1%

0.127

FER1L4

121

2

0.44 (0.16, 0.72)-fixed

0.032

0.0%

0.945

FOXD2-AS1

75

2

1.62 (0.60, 4.38)-fixed

0.344

0.0%

0.948

HNF1A-AS1

115

2

2.63 (1.58, 4.39)-fixed

0.000

0.0%

0.994

HOXA11-AS

112

2

1.78 (0.59, 3.36)-fixed

0.307

0.0%

0.573

HOXD-AS1

89

2

1.61 (1.04, 2.50)-fixed

0.033

0.0%

0.852

HULC

111

2

5.38 (0.62, 46.50)-random

0.126

71.5%

0.061

LSINCT5

166

2

1.59 (1.04, 2.44)-fixed

0.031

0.0%

0.695

MALAT1

605

8

2.15 (1.67, 2.76)-fixed

0.000

0.0%

0.676

MEG3

268

2

0.55 (0.36, 0.84)-fixed

0.005

0.0%

0.770

NEAT1

195

3

1.96 (1.05, 3.68)-fixed

0.035

0.0%

0.983

ODRUL

140

2

1.73 (1.12, 2.67)-fixed

0.013

0.0%

0.793

OIP5-AS1

128

2

1.93 (1.00, 3.73)-fixed

0.049

0.0%

0.367

PCAT1

92

2

2.43 (1.95, 6.24)-random

0.065

87.9%

0.004

PVT1

99

2

1.69 (0.70, 4.06)-fixed

0.241

0.0%

0.974

SNHG12

95

2

1.85 (0.75, 4.58)-fixed

0.181

0.0%

0.733

SNHG16

161

2

1.91 (0.94, 3.86)-fixed

0.074

0.0%

0.498

SNHG20

172

2

1.95 (1.23, 3.09)-fixed

0.004

0.0%

0.940

TP73

178

2

1.90 (1.20, 3.02)-fixed

0.006

0.0%

0.943

TUG1

294

5

1.64 (1.42, 1.92)-fixed

0.000

0.0%

0.435

UCA1

286

2

2.41 (1.42, 4.07)-fixed

0.001

0.0%

0.809

XIST

299

4

1.79 (1.40, 2.30)-fixed

0.000

0.0%

0.601

ZFAS1

103

2

1.47 (0.66, 3.23)-fixed

0.343

0.0%

0.723

  1. CI confidence interval, HR hazard ratio